GGrantIndex
Sort

78,016 grants matching breast cancer

Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways

$832,771
Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

CLIN CTR CLIN TRIAL/OBSERVATIONAL STUDY OF WHI

$832,714
University Of North Carolina Chapel Hill · N01 · FY2000 · WH

Biomarker-Based Phase IIB Trial of (Bazedoxifene-Conjugated Estrogen) to Reduce Risk for Breast Cancer

$832,556
Carol J Fabian · University Of Kansas Medical Center · R01 · FY2023 · CA

A Genetic Approach to Genome-scale Analysis of Cancers

$832,424
Univ Of Med/Dent Nj-R W Johnson Med Sch · R33 · FY2002 · CA

MOLECULAR APPROACHES TO DISCOVER MARINE NATURAL PRODUCT

$832,417
University Of California Santa Cruz · U19 · FY2004 · CA

INTRA- MAMMARY DISTRIBUTION OF TRANSERMAL TELAPRISTONE VERSUS ORAL TELAPRISTONE VERSUS ORAL TELAPRISTONE: A RANDOMIZED WINDOW TRAIL IN WOMEN UNDERGOING MASTECTOMY 08/26/2014 -02/25/2017

$832,339
Raymond Bergan · Northwestern University · N01 · FY2014 · CA

Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ

$831,953
Griffin Rodgers · National Heart, Lung, And Blood Institute · ZIA · FY2011 · HL

Multi-site adaptive trial of a technology-based, EHR-integrated physical activity intervention in breast and endometrial cancer survivors

$831,828
Lisa Anne Cadmusbertram · University Of Wisconsin-Madison · R37 · FY2020 · CA

Targeted Fluorescence Imaging of Nerves for Surgical Guidance

$831,817
Cristina A Tan Hehir · General Electric Global Research Ctr · R01 · FY2013 · EB

Mouse Models of Human Breast Cancer

$831,781
Jeffrey Rosen · Baylor College Of Medicine · U01 · FY2008 · CA

The TOPAS Tool for Particle Simulation, a Monte Carlo Simulation Tool for Physics, Biology and Clinical Research

$831,681
Bruce Faddegon · University Of California, San Francisco · U24 · FY2022 · CA

Preclinical Oxygen Imager to Model Efficient Cancer Treatment

$831,635
Mrignayani Kotecha · O2m Technologies, Llc · R44 · FY2020 · CA

Environmental chemicals and postpubertal breast composition in a Latino cohort

$831,626
Karin B Michels · University Of California Los Angeles · U01 · FY2019 · ES

Early Life Conditions, Survival, and Health: A Pedigree-Based Population Study

$831,456
Ken R Smith · University Of Utah · R01 · FY2014 · AG

The Women's Health Study: Infrastructure Support for Continued Cohort Follow-up

$831,076
Julie E Buring · Brigham And Women'S Hospital · UM1 · FY2016 · CA

A GENETIC INTERACTION SCREEN FOR BREAST CANCER PROGRESSION DRIVER GENES

$830,987
Yale Univ · · FY2012 · Department of the Army

Cell and Chemical Biology of Microtubules

$830,954
Timothy J Mitchison · Harvard Medical School · R35 · FY2023 · GM

Development of FISH Molecular Diagnostics to support Clinical Trials at NCI

$830,915
Svetlana Pack · Division Of Basic Sciences - Nci · ZID · FY2011 · CA

Diagnostic Nodal Staging with Nuclear and NIR Molecular Optical Imaging

$830,910
Eva M Sevick-Muraca · University Of Texas Hlth Sci Ctr Houston · U54 · FY2012 · CA

Mouse Models of Human Breast Cancer

$830,735
Baylor College Of Medicine · U01 · FY2005 · CA

Signaling pathways regulating stem cell fate decisions

$830,704
Ramiro Iglesias-Bartolome · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

DISSECTING THE MECHANISMS OF DRUG RESISTANCE IN BRCA1/2-MUTANT BREAST CANCERS

$830,653
Dana-Farber Cancer Institute, Inc. · · FY2016 · Department of the Army

Trametes Versicolor-Induced Immunopotentiation

$830,591
Joel W Slaton · University Of Minnesota · U19 · FY2006 · AT

BIOSTATISTICS/BIOINFORMATICS

$830,484
Peter D Emanuel · University Of Alabama At Birmingham · P30 · FY2007 · CA

Human Monoclonal Antibodies Against Cancer

$830,477
Dimiter S Dimitrov · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA